Fig. 3.
Meta-analyses on myocardial infarction risk in FVL carriers (heterozygotes + homozygotes).
Studies are listed according to their weight. All, risk of MI including all studies; chi-square test for heterogeneity,P = .61; test for overall effect, P = .02. Men, risk of MI in men only; chi-square test for heterogeneity,P = .95; test for overall effect, P = .15. Women, risk of MI in women only; chi-square test for heterogeneity,P = .07, test for overall effect, P = .80. Premature, risk of MI before age 50 years; chi-square test for heterogeneity, P = .69; test for overall effect,P = .02.